Dr. Harris Rotman joined Centessa in July 2022 as Senior Vice President, Regulatory Affairs. Harris has over 20 years of pharmaceutical industry experience with an additional 8 years of scientific research training. He has experience liaising with various regulatory agencies, and is proficient in investigational development, post-approval activities, application maintenance, advertising/promotion review, and medical writing. Harris has managed multiple worldwide developmental projects for regulatory in neuroscience, cardiovascular, renal, dermatologic, analgesic, addiction, aesthetic, and gastrointestinal therapeutic areas, including rare/orphan disease products. He has worked at Wyeth, Sanofi, Shire, Indivior, Endo, and SwanBio Therapeutics.
Harris received his BS in biological sciences from Rutgers University and his PhD in microbiology and molecular virology from Thomas Jefferson University. He then completed his postdoctoral fellowship at Hahnemann University Hospital.
